phloroglucinol has been researched along with Fatty Liver, Nonalcoholic in 2 studies
Phloroglucinol: A trinitrobenzene derivative with antispasmodic properties that is used primarily as a laboratory reagent.
phloroglucinol : A benzenetriol with hydroxy groups at position 1, 3 and 5.
Excerpt | Relevance | Reference |
---|---|---|
"Nonalcoholic fatty liver disease (NAFLD) is one of the most commonly occurring diseases within western dietary patterns." | 5.62 | Phloroglucinol Strengthens the Antioxidant Barrier and Reduces Oxidative/Nitrosative Stress in Nonalcoholic Fatty Liver Disease (NAFLD). ( Chomentowski, A; Drygalski, K; Krętowski, A; Maciejczyk, M; Odrzygóźdź, C; Siewko, K; Zalewska, A, 2021) |
"Nonalcoholic fatty liver disease (NAFLD) is one of the most commonly occurring diseases within western dietary patterns." | 1.62 | Phloroglucinol Strengthens the Antioxidant Barrier and Reduces Oxidative/Nitrosative Stress in Nonalcoholic Fatty Liver Disease (NAFLD). ( Chomentowski, A; Drygalski, K; Krętowski, A; Maciejczyk, M; Odrzygóźdź, C; Siewko, K; Zalewska, A, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Zhou, X | 1 |
Xu, W | 1 |
Li, Y | 1 |
Zhang, M | 1 |
Tang, P | 1 |
Lu, W | 1 |
Li, Q | 1 |
Zhang, H | 1 |
Luo, J | 1 |
Kong, L | 1 |
Drygalski, K | 1 |
Siewko, K | 1 |
Chomentowski, A | 1 |
Odrzygóźdź, C | 1 |
Zalewska, A | 1 |
Krętowski, A | 1 |
Maciejczyk, M | 1 |
2 other studies available for phloroglucinol and Fatty Liver, Nonalcoholic
Article | Year |
---|---|
Anti-Inflammatory, Antioxidant, and Anti-Nonalcoholic Steatohepatitis Acylphloroglucinol Meroterpenoids from
Topics: Anti-Inflammatory Agents; Antioxidants; Flowers; Humans; Hypericum; Molecular Structure; Non-alcohol | 2021 |
Phloroglucinol Strengthens the Antioxidant Barrier and Reduces Oxidative/Nitrosative Stress in Nonalcoholic Fatty Liver Disease (NAFLD).
Topics: Antioxidants; Hep G2 Cells; Humans; Nitrosative Stress; Non-alcoholic Fatty Liver Disease; Phloroglu | 2021 |